CGON (CG Oncology) Purchase Of Property, Plant, Equipment : $-0.03 Mil (TTM As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is CG Oncology Purchase Of Property, Plant, Equipment?

CG Oncology's purchase of property, plant, equipment for the three months ended in Sep. 2024 was $0.00 Mil. It means CG Oncology spent $-0.00 Mil on purchasing property, plant, equipment. CG Oncology's purchase of property, plant, equipment for the trailing twelve months (TTM) ended in Sep. 2024 was $-0.03Mil.

Compared with last quarter ($-0.01 Mil in Jun. 2024 ), CG Oncology spent less money on purchasing property, plant, equipment in Sep. 2024 ($0.00 Mil).

CG Oncology Purchase Of Property, Plant, Equipment Historical Data

The historical data trend for CG Oncology's Purchase Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CG Oncology Purchase Of Property, Plant, Equipment Chart

CG Oncology Annual Data

Trend

Dec21

Dec22

Dec23

Purchase Of Property, Plant, Equipment

-0.10

-0.01

CG Oncology Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Purchase Of Property, Plant, Equipment	Get a 7-Day Free Trial					0.01	-	-0.01	-0.01	-

CG Oncology Purchase Of Property, Plant, Equipment Calculation

The amount used to purchase PPE.

Purchase Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.03 Mil.

CG Oncology Purchase Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of CG Oncology's Purchase Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.

CG Oncology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CG Oncology Inc (NAS:CGON) » Definitions » Purchase Of Property, Plant, Equipment

Comparable Companies

Traded in Other Exchanges

N/A

Address

400 Spectrum Center Drive, Suite 2040, Irvine, CA, USA, 92618

Website

https://www.cgoncology.com

CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.